James Garner, Kazia CEO (PR Newswire)
Kazia swipes an ex-Sanofi molecule for £1M upfront as they look to replicate their Genentech snag
Kazia has spent most of its young life trying to develop a single Genentech castoff it swiped for $5 million into a brain cancer drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
